Literature DB >> 31219473

Prevalencia de derrame pericárdico en enfermedades sistémicas.

Oscar Orihuela-Rodríguez1, Héctor Carmona-Ruiz1.   

Abstract

INTRODUCTION: The presence of 50 mL of fluid or more in the pericardial sac is known as pericardial effusion.
OBJECTIVE: To determine the prevalence of pericardial effusion in patients with systemic diseases.
METHOD: Echocardiographic studies performed at the National Medical Center Siglo XXI Specialty Hospital Cardiology Department between 2006 and 2016 were reviewed. According to Weitzman's criteria, pericardial effusion was classified as mild, < 10 mm, moderate, 10 to 20 mm and severe, > 20 mm.
RESULTS: In total, 10,653 studies were reviewed; the prevalence of pericardial effusion was 3.5 % (380), in 209 women (55 %, 45.9 ± 19.0 years) and 171 men (45 %, 41.9 ± 18.5 years). Etiology was uremic in 227 (59.7 %), lymphatic drainage reduction in 73 (15.8 %), autoimmune diseases in 30 (7.9 %), neoplastic in 26 (6.8 %), infectious in 19 (5 %), idiopathic in 14 (3.7 %), hypothyroidism in two (0.5 %), iatrogenic in one (0.3 %) and post-infarction in one (0.3 %). Severity was mild in 87 (22.9 %), moderate in 147 (38.7 %) and severe in 146 (38.4 %).
CONCLUSIONS: The prevalence of pericardial effusion was 3.5% in patients with systemic diseases. Copyright:
© 2019 SecretarÍa de Salud.

Entities:  

Keywords:  Derrame pericárdico; Enfermedades sistémicas; Pericardial effusion; Prevalence; Prevalencia; Systemic diseases

Mesh:

Year:  2019        PMID: 31219473     DOI: 10.24875/GMM.19004444

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  1 in total

1.  Pericardial-Peritoneal Window as an Alternative Treatment for Large and Recurrent Pericardial Effusion Post-Pericardiotomy.

Authors:  Luis Roberto Palma Dallan; Luis Alberto Oliveira Dallan; Omar Vilca Mejía; Luis Augusto Palma Dallan; Luiz Augusto Ferreira Lisboa; Fabio B Jatene
Journal:  Braz J Cardiovasc Surg       Date:  2021-08-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.